Upper Arlington, OH, United States of America

Jeffrey Taylor Stroup

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2002-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Taylor Stroup

Introduction

Jeffrey Taylor Stroup is a notable inventor based in Upper Arlington, OH (US). He has made significant contributions to the field of radiopharmaceuticals, holding a total of five patents. His work focuses on the systems and methods for producing and controlling radiopharmaceuticals, which are crucial in medical applications.

Latest Patents

Stroup's latest patents include advanced systems, methods, and devices for generating radionuclides used in the production of radiopharmaceuticals. These innovations involve synthesizing radionuclides, measuring their quantity and activity levels, and ensuring the safe and efficient production of radiopharmaceutical outputs. His patents also cover the delivery of non-radionuclide components, purification processes, and automated quality control measures. These inventions aim to enhance the efficiency and safety of radiopharmaceutical production, ultimately benefiting medical practices.

Career Highlights

Throughout his career, Stroup has worked with prominent organizations such as Cardinal Health 414, LLC and Battelle Memorial Institute. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of radiopharmaceuticals.

Collaborations

Stroup has collaborated with notable professionals in his field, including Thomas Alan Klausing and Brian Charles Kelley. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Jeffrey Taylor Stroup's contributions to the field of radiopharmaceuticals through his innovative patents and collaborations highlight his significant impact on medical technology. His work continues to pave the way for advancements in the production and control of radiopharmaceuticals, ultimately enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…